The global atopic dermatitis drugs market should grow with a CAGR of 4.77% over the forecast period. The base year considered for the study is 2017 and the forecast period is 2019-2027

Friday, October 19, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Oct. 18, 2018 /PRNewswire/ -- KEY FINDINGSAccording to market expectations, the global atopic dermatitis drugs

market should grow with a CAGR of 4.77% over the forecast period. The base year considered for the study is 2017 and the forecast period is 2019-2027.Download the full report: https://www.reportbuyer.com/product/5377447 The global atopic dermatitis
drugs market is primarily driven by factors such as the increasing prevalence of food allergies causing atopic dermatitis, the rising focus on systematic therapies and the ever increasing use of pharmacological products in developing countriesMARKET INSIGHTSThe important driver increasing growth in the global atopic dermatitis drugs market is the high prevalence of food allergies exacerbating atopic dermatitis.It is estimated that food allergy and severe atopic dermatitis coexist in about one-third of all children with atopic dermatitis.The atopic dermatitis drugs market is broadly classified into two segments on the basis of drug classes and the route of administration.REGIONAL INSIGHTSThis report broadly segregates the atopic dermatitis drug market into four geographies namely-Europe, Asia-Pacific, North America and Rest of the World.The atopic dermatitis drugs market in North America is expected to hold the largest share by 2027.This sudden yet steady growth in the North American regional market is attributed to the high prevalence of allergic conditions in the existing population. The United States holds the largest revenue share in global atopic dermatitis drugs market country-wise.COMPETITIVE INSIGHTSLeading players in the global atopic dermatitis drug market are Allergan Plc, Aqua Pharmaceuticals (An Almirall Company), Astellas Pharma Inc., Bayer Ag, Biofrontera Ag,Bristol-Myers Squibb,Stiefel Laboratories Inc, Encore Dermatology, Galderma Sa, Leo Pharma, Meda Pharmaceuticals (Mylan N.V.),Novartis Ag, Pfizer, Regeneron Pharmaceuticals, Sanofi Sa, Valent Pharmaceutical Inc. and several others.Download the full report: https://www.reportbuyer.com/product/5377447 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: sarah@reportbuyer.com Tel: +1 (718) 213 4904 Website: www.reportbuyer.com

Cision View original content:http://www.prnewswire.com/news-releases/the-global-atopic-dermatitis-drugs-market-should-grow-with-a-cagr-of-4-77-over-the-forecast-period-the-base-year-considered-for-the-study-is-2017-and-the-forecast-period-is-2019-2027--300733807.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store